These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8396759)

  • 1. [Quantitative assessment of lipiodol delivered intra-arterially into hepatoma: with evaluation of MR signal intensity].
    Harada M; Yamashita Y; Yamamoto H; Yoshimatsu S; Sakamoto Y; Takahashi M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):903-10. PubMed ID: 8396759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of emulsion containing Gd-DTPA and lipiodol in hepatic transcatheter arterial embolization.
    Shiono T; Yoshikawa K; Hisamatsu K; Takenaka E
    Radiat Med; 1993; 11(5):187-90. PubMed ID: 8290693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
    Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
    Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
    Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of concentrated CDDP-lipiodol emulsion for hepatic arterial infusion therapy in patients with nonresectable hepatoma].
    Nakashima K; Iwao Y; Suzuki K; Tada I; Kim YI; Kobayashi M; Mori K; Takayama F; Takeyama M; Aikawa H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1731-5. PubMed ID: 2167645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological and clinical studies on lipiodol emulsion for hepatocellular carcinoma].
    Kodama T; Arima K; Sakamoto H; Suga M; Yachi A
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2544-8. PubMed ID: 2843121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Accumulation of lipiodol in hepatocellular carcinoma after transarterial chemoembolization with 5 FU-lipiodol-emulsion].
    Okada K; Tada I; Suzuki K; Kim YI; Kobayashi M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2557-61. PubMed ID: 2843123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings.
    Matsuo N; Uchida H; Sakaguchi H; Nishimine K; Nishimura Y; Hirohashi S; Ohishi H
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-61-S6-70. PubMed ID: 9151919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence.
    Murakami R; Yoshimatsu S; Yamashita Y; Sagara K; Arakawa A; Takahashi M
    Acta Radiol; 1994 Nov; 35(6):576-80. PubMed ID: 7946681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
    Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
    Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemoembolization].
    Nakamura H; Hashimoto T; Taguchi T; Oi H; Nakagawa K; Inoue K; Seki K; Mizumoto S; Akashi H; Tsukaguchi I
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1656-63. PubMed ID: 3036013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of viable tumor cells in hepatocellular carcinoma following transcatheter arterial chemoembolization with iodized oil. Pathologic correlation with dynamic turbo-FLASH MR imaging with Gd-DTPA.
    Murakami T; Nakamura H; Hori S; Tomoda K; Mitani T; Nakanishi K; Hashimoto T; Tsuda K; Kozuka T; Monden M
    Acta Radiol; 1993 Jul; 34(4):399-403. PubMed ID: 8391291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
    Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on the effect of intra-arterial injection of mitoxantrone-lipiodol emulsion for hepatocellular carcinoma].
    Ichikawa W; Togo S; Osanai T; Miyanaga T; Sawai S; Yamashita T; Kawachi Y; Nihei Z; Hirayama R; Mishima Y
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2212-4. PubMed ID: 7944442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dense parenchymal accumulation of Lipiodol after transarterial chemoembolization.
    Hihara T; Araki T; Kachi K; Monzawa S; Uchiyama G
    Radiat Med; 1992; 10(3):79-81. PubMed ID: 1324510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of lipiodol on MR images evaluation by dynamic MR imaging with intraarterial lipiodol injection in the rabbit VX-2 tumor].
    Ito K; Fujita T; Homma Y; Sasai K; Nakanishi T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 May; 53(5):596-8. PubMed ID: 8392169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity reactions to transcatheter chemoembolization with cisplatin and Lipiodol suspension for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Katamura Y; Takaki S; Waki K; Hiramatsu A; Takahashi S; Hieda M; Kakizawa H; Chayama K
    J Vasc Interv Radiol; 2010 Aug; 21(8):1219-25. PubMed ID: 20619676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma platinum concentration and anti-tumor effects after intra-arterial infusion of lipiodol-CDDP suspension evaluation with VX 2 rabbit liver cancer model and 7.0 Tesla MRI system].
    Sonoda A; Nitta N; Ohta S; Itoh R; Takahashi M; Murata K; Morikawa S; Inubushi T; Miyagawa Y; Takamori M; Oonaka Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):951-7. PubMed ID: 16835486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.